Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sramek

Showing results (91-100 of 156) with videos related to

Pageof 16
Sort By:
Anxiety|January 1, 1994
Single-site findings in a study of the safety and efficacy of a CCKB receptor antagonist, CI-988, in the treatment of generalized anxiety disorderJ J Sramek, J F Costa, J B Adams, et al.
International Journal of Psychosomatics : Official Publication of the International Psychosomatics Institute|January 1, 1991
Adjunctive clonazepam in the treatment of chronic schizophreniaJ M Herrera, W A Alvarez, J P Freinhar, et al.
The Annals of Pharmacotherapy|December 10, 1997
Ethnicity and antipsychotic responseE J Frackiewicz, J J Sramek, J M Herrera, et al.
The Annals of Pharmacotherapy|January 1, 1994
Fleroxacin treatment of stage IV pressure ulcers with associated osteomyelitisN R Cutler, R D Seifert, J J Sramek, et al.
Drug Intelligence & Clinical Pharmacy|March 1, 1988
Pharmacy-based screening program for tardive dyskinesiaT N Ahrens, J J Sramek, J M Herrera, et al.
Alzheimer Disease and Associated Disorders|January 7, 1999
Efficacy of xanomeline in Alzheimer disease: cognitive improvement measured using the Computerized Neuropsychological Test Battery (CNTB)A E Veroff, N C Bodick, W W Offen, et al.
The Annals of Pharmacotherapy|December 1, 1996
Efficacy and safety of BMY 21,502 in Alzheimer diseaseR C Shrotriya, N R Cutler, J J Sramek, et al.
Current Eye Research|October 1, 1993
Ocular renin angiotensin: EM immunocytochemical localization of proreninI H Wallow, S J Sramek, C D Bindley, et al.
Life Sciences|January 1, 1995
Safety and tolerability of CI-979 in patients with Alzheimer's diseaseJ J Sramek, A J Sedman, P A Reece, et al.
Journal of Human Hypertension|November 1, 1995
Anti-hypertensive effects of intravenous compared with oral captoprilJ J Sramek, J J Brennan, D R Much, et al.
Pageof 16

Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
Anxiety|January 1, 1994
Single-site findings in a study of the safety and efficacy of a CCKB receptor antagonist, CI-988, in the treatment of generalized anxiety disorderJ J Sramek, J F Costa, J B Adams, et al.
International Journal of Psychosomatics : Official Publication of the International Psychosomatics Institute|January 1, 1991
Adjunctive clonazepam in the treatment of chronic schizophreniaJ M Herrera, W A Alvarez, J P Freinhar, et al.
The Annals of Pharmacotherapy|December 10, 1997
Ethnicity and antipsychotic responseE J Frackiewicz, J J Sramek, J M Herrera, et al.
The Annals of Pharmacotherapy|January 1, 1994
Fleroxacin treatment of stage IV pressure ulcers with associated osteomyelitisN R Cutler, R D Seifert, J J Sramek, et al.
Drug Intelligence & Clinical Pharmacy|March 1, 1988
Pharmacy-based screening program for tardive dyskinesiaT N Ahrens, J J Sramek, J M Herrera, et al.
Alzheimer Disease and Associated Disorders|January 7, 1999
Efficacy of xanomeline in Alzheimer disease: cognitive improvement measured using the Computerized Neuropsychological Test Battery (CNTB)A E Veroff, N C Bodick, W W Offen, et al.
The Annals of Pharmacotherapy|December 1, 1996
Efficacy and safety of BMY 21,502 in Alzheimer diseaseR C Shrotriya, N R Cutler, J J Sramek, et al.
Current Eye Research|October 1, 1993
Ocular renin angiotensin: EM immunocytochemical localization of proreninI H Wallow, S J Sramek, C D Bindley, et al.
Life Sciences|January 1, 1995
Safety and tolerability of CI-979 in patients with Alzheimer's diseaseJ J Sramek, A J Sedman, P A Reece, et al.
Journal of Human Hypertension|November 1, 1995
Anti-hypertensive effects of intravenous compared with oral captoprilJ J Sramek, J J Brennan, D R Much, et al.
Pageof 16